Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BIO-RAD LABORATORIES, INC. Director's Dealing 2019

May 16, 2019

30786_dirs_2019-05-15_6d7f2d04-55eb-487e-bfca-ffac990a2a1f.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIO-RAD LABORATORIES, INC. (BIO, BIOB)
CIK: 0000012208
Period of Report: 2019-05-15

Reporting Person: Magni Giovanni (EVP, Chief Strategy Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2019-05-15 Bio-Rad A Common Stock M 3500 $74.27 Acquired 15420 Direct
2019-05-15 Bio-Rad A Common Stock F 1803 $290.6279 Disposed 13617 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2019-05-15 Non-Qualified Stock Option (right to buy) $74.27 M 3500 Disposed 2019-06-10 Bio-Rad A Common Stock (3500) Direct

Footnotes

F1: The option vested in five equal annual installments beginning on June 10, 2010.